ExploreWatchlistsPricing
  1. JP-listed companies
  2. Alfresa Holdings Corporation
  3. Financials
  4. Depreciation & amortization

Alfresa Holdings Corporation (2784)

Market cap
¥417.9B
P/E ratio
18.8x
Alfresa Holdings distributes prescription drugs, medical devices, and healthcare products to serve Japan's medical industry through specialized subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndDepreciation & amortization (Million JPY)YoY (%)
Mar 31, 202614,647+1.55%
Mar 31, 202514,424+10.82%
Mar 31, 202413,016+1.66%
Mar 31, 202312,804+4.95%
Mar 31, 202212,200+8.53%
Mar 31, 202111,241+3.27%
Mar 31, 202010,885+14.30%
Mar 31, 20199,523+2.86%
Mar 31, 20189,258+1.17%
Mar 31, 20179,151-0.73%
Mar 31, 20169,218+11.63%
Mar 31, 20158,258

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat